Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients

Grassi, 2016, Hepatitis C virus relies on lipoproteins for its life cycle, World J Gastroenterol, 22, 1953, 10.3748/wjg.v22.i6.1953 Popesscu, 2014, Hepatitis C virus life cycle and lipid metabolism, Biology (Basal), 3, 892, 10.3390/biology3040892 Long, 2011, Mouse hepatic cells support assembly of infectious hepatitis C virus particles, Gastroenterology, 141, 1057, 10.1053/j.gastro.2011.06.010 Merz, 2011, Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome, J Biol Chem, 286, 3018, 10.1074/jbc.M110.175018 Hishiki, 2010, Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms, J Virol, 84, 12048, 10.1128/JVI.01063-10 Nielsen, 2006, Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients, J Virol, 80, 2418, 10.1128/JVI.80.5.2418-2428.2006 André, 2005, Hepatitis C virus particles and lipoprotein metabolism, Semin Liver Dis, 25, 93, 10.1055/s-2005-864785 Bassendine, 2011, HCV and the hepatic lipid pathway as a potential treatment target, J Hepatol, 55, 1428, 10.1016/j.jhep.2011.06.004 Eichner, 2002, Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review, Am J Epidemiol, 155, 487, 10.1093/aje/155.6.487 National Center for Biotechnology Information, Database Single Nucleotide Polymorphism. <http://www.ncbi.nlm.nih.gov/snp?term=apoE>. Radmanesh, 2014, Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data, Eur J Hum Genet, 22, 1239, 10.1038/ejhg.2013.308 Huebbe, 2010, Implications of apolipoprotein E genotype on status, Mol Nutr Food Res, 54, 623, 10.1002/mnfr.200900398 Spada, 2004, Multispecific T cell response and negative HCV-RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance, Gut, 53, 1673, 10.1136/gut.2003.037788 Sahu, 2005, Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus Friedewald estimation, Indian J Clin Biochem, 20, 54, 10.1007/BF02867401 Fulton, 2009, Effects of apolipoprotein E genotype on blood cholesterol in adolescent girls, Am J Prev Med, 37, S78, 10.1016/j.amepre.2009.04.009 Noppornpanth, 2006, Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5′ untranslated regions, J Clin Microbiol, 3969, 10.1128/JCM.01122-06 Pogam, 1998, Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping, J Clin Microbiol, 1461, 10.1128/JCM.36.5.1461-1463.1998 Andre C, Chen F, Pandey V, Kurtz R, Batey D. Haplotype analysis using a novel real time amplification strategy on the MJ Research Opticon continuous fluorescence detection system. MJ Res 2004;888. <www.mjresearch.com>. Minihane, 2007, Rimbach G: ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation, Proc Nutr Soc, 66, 183, 10.1017/S0029665107005435 Mueller, 2016, Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection, Liver Int, 36, 1267, 10.1111/liv.13094 Marz, 2004, The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study), Eur Heart J, 25, 2109, 10.1016/j.ehj.2004.08.024 Price, 2006, Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection, Gut, 55, 715, 10.1136/gut.2005.079905 Teama, 2016, Apolipoprotein-E gene polymorphism and possible role of ApoE ε4 allele with a lower probability of progression to HCV-related liver cirrhosis in Egyptian patient, Merit Res J Med Med Sci, 4, 440 Kuhlmann I, Minihane, Patricia H, Nebel A, Rimbach G. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 2010;9:8. Sheridan, 2009, Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin, Aliment Pharmacol Ther, 29, 1282, 10.1111/j.1365-2036.2009.04012.x Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 2002;36(2):456–63. Serfaty C, Andreani T, Giral P. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001;34:428–34. Dubuisson, 2002, Interaction of hepatitis C virus proteins with host cell membranes and lipids, Trends Cell Biol, 12, 517, 10.1016/S0962-8924(02)02383-8 Marzouk, 2007, Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt, Gut, 65, 1105, 10.1136/gut.2006.091983 Corey, 2009, HepatitisCvirus infection and its clearance alter circulating lipids: implications for long term follow up, Hepatology, 50, 1030, 10.1002/hep.23219 Nashaat, 2010, Lipid profile among chronic hepatitis C Egyptian patients and its levels pre and post treatment, Nat Sci, 8, 83 Perlemuter G, Sabile A, Lettteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steato-sis. FASEB J 2002;16:185–94. Lee, 2014, Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins, J Virol, 88, 12422, 10.1128/JVI.01660-14 Andre, 2002, Characterization of low- and very-low-density hepatitis C virus RNA containing particles, J Virol, 76, 6919, 10.1128/JVI.76.14.6919-6928.2002